glutathione clinical trial news 2025 A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer Glutathione: Benefits and Supplements
Glutathione: Benefits and Supplements Join us at the 9th Dermatology Drug Development Summit 2025 in Boston Glutathione (Reduced), Sodium Salt Application in Therapy and Current Clinical Research The Annual Clinical Trials Roundup, 2025 Edition Citeline Glutathione accelerates the cell cycle and cellular reprogramming in plant regeneration: Developmental Cell Glutaminase inhibitor CB 839 causes metabolic adjustments in colorectal cancer cells Scientific Reports
Pay in 4 interest-free payments of $5.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




